Combining leptin with liraglutide restored glucose levels to healthy-mouse levels in insulin-dependent diabetic mice, suggesting two peptide hormones together might someday reduce insulin dependence.
Glucose normalized to healthy levelsLeptin + liraglutide combination achieved glucose metabolism comparable to non-diabetic control mice, without insulin
What the researchers found
Combining leptin and liraglutide (a GLP-1 receptor agonist) normalized blood glucose levels in mice with insulin-dependent diabetes — achieving glucose control comparable to healthy mice, without any insulin treatment.
Each peptide worked on its own: both leptin monotherapy and liraglutide monotherapy significantly improved blood glucose levels and glucose tolerance compared to untreated diabetic mice. But the combination (LEP+LIRA) outperformed either alone, restoring glucose metabolism to levels indistinguishable from healthy control mice.
Why it matters
Type 1 diabetes currently requires lifelong insulin injections. If a combination of leptin and a GLP-1 agonist could partially or fully replace insulin in some patients, it could fundamentally change treatment options. This animal study provides early proof-of-concept that two non-insulin peptide hormones working together can achieve what neither does alone — complete glucose normalization in insulin-dependent diabetes.
The numbers in context
Leptin: 20 μg/day via osmotic pump · Liraglutide: 1000 μg/kg/day subcutaneously · LEP+LIRA glucose levels comparable to healthy controls · STZ-induced IDDM in 12-week-old C57BL/6J mice
How the study worked
Researchers induced insulin-dependent diabetes in male mice using high-dose streptozotocin (which destroys insulin-producing beta cells). Diabetic mice were divided into four groups: leptin alone, liraglutide alone, leptin plus liraglutide, and untreated. A fifth group of healthy mice served as controls. Blood glucose was measured and glucose tolerance tests were performed to compare all five groups.
Who was studied
Male C57BL/6J mice, 12 weeks old, with streptozotocin-induced insulin-dependent diabetes
What this study cannot tell us
This is a mouse study using chemically induced diabetes, which doesn't perfectly replicate human type 1 diabetes (an autoimmune disease). The abstract doesn't report specific glucose numbers, sample sizes per group, or statistical comparisons between the combination and monotherapy groups. Streptozotocin-induced diabetes destroys beta cells but lacks the autoimmune component. Long-term safety and durability of the effect were not assessed.
How to read the evidence
This is a preliminary animal study using a chemically induced diabetes model. While the glucose normalization result is striking, no human data exists and the model doesn't fully replicate human type 1 diabetes.
When this study was published
Published in 2025, this is a very recent study representing current research into multi-peptide approaches to insulin-dependent diabetes management.
The bigger picture
GLP-1 agonists like liraglutide are already blockbuster drugs for type 2 diabetes and obesity, but their role in type 1 diabetes is mostly unexplored. Leptin has been studied in lipodystrophy and as an insulin adjunct. This study's finding that combining these two peptides can fully normalize glucose without insulin adds to growing interest in multi-hormone approaches to diabetes that go beyond insulin monotherapy.
Questions still open
- Would this leptin-liraglutide combination work in autoimmune models of type 1 diabetes, not just chemically induced beta cell destruction?
- Could this combination reduce (rather than eliminate) insulin requirements in human type 1 diabetes patients?
- What mechanisms allow leptin and GLP-1 agonists to synergize for glucose control when beta cells are largely absent?
Common questions
Could leptin and liraglutide replace insulin in people with type 1 diabetes?
Why would leptin help with blood sugar control in diabetes?
Read the original research
Effects of Combination Treatment with Leptin and Liraglutide on Glucose Metabolism in Insulin-Dependent Diabetic Mice.
International journal of molecular sciences, 26(10)
Citation
Fu, Linlin; Sugiyama, Mariko; Kamal, Shahriar; Ide, Tsubasa; Takeda, Tadashi; Kuno, Mitsuhiro; Takagi, Hiroshi; Koike, Teruhiko; Arima, Hiroshi; Banno, Ryoichi. (2025). Effects of Combination Treatment with Leptin and Liraglutide on Glucose Metabolism in Insulin-Dependent Diabetic Mice.. International journal of molecular sciences, 26(10). https://doi.org/10.3390/ijms26104595